Chinese medicine neuroaid efficacy on stroke recovery: A double-blind, placebo-controlled, randomized study

Chinese medicine neuroaid efficacy on stroke recovery: A double-blind, placebo-controlled, randomized study

BACKGROUND AND PURPOSE-: Previous clinical studies suggested benefit for poststroke recovery when MLC601 was administered between 2 weeks and 6 months of stroke onset. The Chinese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES) study tested the hypothesis that MLC601 is superior to placebo in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Christopher L.H. Chen, Sherry H.Y. Young, Herminigildo H. Gan, Rajinder Singh, Annabelle Y. Lao, Alejandro C. Baroque, Hui Meng Chang, John Harold B. Hiyadan, Carlos L. Chua, Joel M. Advincula, Sombat Muengtaweepongsa, Bernard P.L. Chan, H. Asita De Silva, Somchai Towanabut, Nijasri C. Suwanwela, Niphon Poungvarin, Siwaporn Chankrachang, K. S.Lawrence Wong, Gaik Bee Eow, Jose C. Navarro, Narayanaswamy Venketasubramanian, Chun Fan Lee, Marie Germaine Bousser
Format:	Journal
Published:	2018
Subjects:	Medicine Nursing
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84880803598&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52837
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Chinese medicine neuroaid efficacy on stroke recovery: A double-blind, placebo-controlled, randomized study
by: Christopher L.H. Chen, et al.
Published: (2018)

Prognostic factors and pattern of long-term recovery with MLC601 (NeuroAiD™) in the Chinese medicine NeuroAiD efficacy on stroke recovery - Extension study
by: Venketasubramanian, N, et al.
Published: (2020)

A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study)
by: N. Venketasubramanian, et al.
Published: (2018)

Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study
by: Venketasubramanian, Narayanaswamy, et al.
Published: (2021)

NeuroAid II (MLC901) in Haemorrhagic Stroke
by: Chai-Hoon Nowel Tan, et al.
Published: (2021)

The NeuroAiD II (MLC901) in Vascular Cognitive Impairment Study (NEURITES)
by: Chen, Christopher L.H., et al.
Published: (2017)

Safety profile of MLC601 (Neuroaid®) in acute ischemic stroke patients: A Singaporean substudy of the chinese medicine neuroaid efficacy on stroke recovery study
by: Young, S.H.Y., et al.
Published: (2011)

Prognostic factors and treatment effect in the CHIMES study
by: Siwaporn Chankrachang, et al.
Published: (2018)

Prognostic factors and treatment effect in the CHIMES study
by: Siwaporn Chankrachang, et al.
Published: (2018)

CHIMES-I: Sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study
by: Navarro, J.C., et al.
Published: (2016)

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
by: Chen, C.L.H., et al.
Published: (2021)

Impact of current antiretroviral therapies on neuroAIDS
by: Pornpun Vivithanaporn, et al.
Published: (2018)

The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES) for the NEURITE investigators
by: Chen, C.L.H., et al.
Published: (2014)

Durability of the beneficial effect of MLC601 (NeuroAiD™) on functional recovery among stroke patients from the Philippines in the CHIMES and CHIMES-E studies
by: Navarro, J.C, et al.
Published: (2020)

NeuroAiD (R) (MLC601) and Amyloid Precursor Protein Processing
by: Lim, YA, et al.
Published: (2021)

Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies
by: Suwanwela N.C., et al.
Published: (2019)

Thai venous stroke prognostic score: TV-SPSS
by: Niphon Poungvarin, et al.
Published: (2018)

Thai venous stroke prognostic score: TV-SPSS
by: Niphon Poungvarin, et al.
Published: (2018)

Thai venous stroke prognostic score: TV-SPSS
by: Niphon Poungvarin, et al.
Published: (2018)

The Effect of MLC601 (NeuroAid) on Neurological Outcome of Traumatic Brain Injury Patients
by: Krisna Tsaniadi Prihastomo, NIM011228206301
Published: (2018)

Prevalence of stroke and stroke risk factors in thailand: Thai epidemiologic stroke (TES) study
by: Suchat Hanchaiphiboolkul, et al.
Published: (2018)

Factors predicting high estimated 10-year stroke risk: Thai epidemiologic stroke study
by: Suchat Hanchaiphiboolkul, et al.
Published: (2018)

Risk of metabolic syndrome for stroke is not greater than the sum of its components: Thai Epidemiologic Stroke (TES) study
by: Suchat Hanchaiphiboolkul, et al.
Published: (2018)

Efficacy and safety of MLC601 (NeuroAiD®), a traditional chinese medicine, in poststroke recovery: A systematic review
by: Siddiqui, F.J., et al.
Published: (2014)

Grave prognosis on spontaneous intracerebral haemorrhage: GP on stage score
by: Niphon Poungvarin, et al.
Published: (2018)

A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional Chinese medicine neuroaid (MLC 601) in enhancing recovery after stroke (TIERS)
by: Kong, K.H., et al.
Published: (2016)

Systematic Review and Meta-Analysis of the Efficacy of MLC901 (NeuroAID IITM) for Acute Ischemic Brain Injury in Animal Models
by: I G M Aswin R Ranuh, Ranuh, et al.

Quality of acute ischemic stroke care in thailand: A prospective multicenter countrywide cohort study
by: Yongchai Nilanont, et al.
Published: (2018)

Systematic Review and Meta-Analysis of the Efficacy of MLC901 (NeuroAiD IITM) for Acute Ischemic Brain Injury in Animal Models
by: I G M Aswin R Ranuh, Ranuh, et al.

NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo-controlled randomized trial
by: Chen, CLH, et al.
Published: (2022)

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura
by: Siwaporn Chankrachang, et al.
Published: (2018)

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura
by: Siwaporn Chankrachang, et al.
Published: (2018)

A study on the feasibility of establishing a bowling center
by: Blanco, Herminigildo M.
Published: (1968)

A randomized controlled study of intravenous fluid in acute ischemic stroke
by: Nijasri C. Suwanwela, et al.
Published: (2018)

A randomized controlled study of intravenous fluid in acute ischemic stroke
by: Nijasri C. Suwanwela, et al.
Published: (2018)

Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series
by: Suwanwela N.C.
Published: (2023)

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura
by: Chankrachang S., et al.
Published: (2014)

A STUDY OF THE PATTERN OF MENTAL DISEASE IN BURMANS
by: RAJINDER SINGH GREWAL
Published: (2020)

A STUDY OF THE PATTERN OF MENTAL DISEASE IN BURMANS
by: RAJINDER SINGH GREWAL
Published: (2020)

Big data visualizations for an IoT enabled production facility
by: Eow, Doo Nee
Published: (2020)